Recurrent dislocation: scientific evidence and management following a systematic review.

Recurrent mandibular dislocation is a rare condition that can have a negative impact on quality of life. Different surgical techniques are employed in the treatment of this condition, and the demand for maximum healthcare quality has contributed to the implementation of evidence-based clinical practice. The objective of this study was to determine the level of scientific evidence in articles reporting open surgical treatment for recurrent mandibular dislocation. A comprehensive search strategy was conducted to locate relevant articles in the PubMed and Web of Science databases on open surgical treatment for recurrent mandibular dislocation published between January 1974 and August 2014. These were classified into one of the five established levels/sublevels of evidence: the level of evidence was determined based on the classification proposed by the Oxford Centre for Evidence-Based Medicine. One hundred and fourteen articles were identified, 91 of which were excluded based on the eligibility criteria. Thus, 23 articles were selected for inclusion in the review. All of the selected articles were rated as level 4 (low quality) regarding the level of evidence. The present review revealed that articles on open surgical treatment for recurrent mandibular dislocation exhibit a low level of scientific evidence. Thus, further studies on this topic with greater methodological rigour are needed.

Clinical effects of an avocado-soybean unsaponifiable extract on arthralgia and osteoarthritis of the temporomandibular joint: preliminary study.

The aim of the present preliminary study was to investigate the effectiveness of an avocado-soybean unsaponifiable extract (ASU) in patients with arthralgia and osteoarthritis of the temporomandibular joint (TMJ). A randomized, double-blind, placebo-controlled trial was carried out. Fourteen women diagnosed with arthralgia and osteoarthritis of the TMJ using the Research Diagnostic Criteria for Temporomandibular Disorders were included in the statistical analysis. The women were allocated randomly to two groups: ASU group and placebo group. Pain was measured using a visual analogue scale and pressure algometer. Mandibular function was evaluated through measurement of mandibular movements. Quality of life was measured using the Oral Health Impact Profile (OHIP-14). The medication (ASU capsules or placebo capsules) was used for 4 months and the total follow-up was 6 months. Those taking the ASU extract had a decrease in pain symptoms and an improvement in quality of life. Moreover, a significant reduction in the use of rescue medication was found in the ASU group compared to the placebo group. This preliminary study provides strong evidence of the effectiveness of an avocado-soybean unsaponifiable extract in patients with degenerative joint diseases and arthralgia in the TMJ. Further studies with larger samples should be performed.

Effect of the use of combination uridine triphosphate, cytidine monophosphate, and hydroxycobalamin on the recovery of neurosensory disturbance after bilateral sagittal split osteotomy: a randomized, double-blind trial.

The change in neurosensory lesions that develop after bilateral sagittal split osteotomy (BSSO) was explored, and the influence of the application of combination uridine triphosphate (UTP), cytidine monophosphate (CMP), and hydroxycobalamin (vitamin B12) on patient outcomes was assessed. This was a randomized, controlled, double-blind trial. The study sample comprised 12 patients, each evaluated on both sides (thus 24 sides). All patients fulfilled defined selection criteria. Changes in the lesions were measured both subjectively and objectively. The sample was divided into two patient groups: an experimental group receiving medication and a control group receiving placebo. The statistical analysis was performed using SPSS software. Lesions in both groups improved and no statistically significant difference between the groups was observed at any time. 'Severe' injuries in the experimental group were more likely to exhibit a significant improvement after 6 months. Based on the results of the present study, it is concluded that the combination UTP, CMP, and hydroxycobalamin did not influence recovery from neurosensory disorders.